Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients

被引:75
作者
Kucher, N
Tapson, VF
Goldhaber, SZ
机构
[1] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA
[2] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
关键词
deep vein thrombosis; pulmonary embolism; venous thromboembolism;
D O I
10.1160/TH04-09-0587
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In patients with deep vein thrombosis (DVT), the factors which predispose to concomitant symptomatic pulmonary embolism (PE) have remained uncertain. From a prospective cohort of 5,451 consecutive patients with ultrasound-confirmed DVT we analyzed 4,211 patients with a known status for presence (n = 639) or absence (n = 3572) of symptomatic PE. Age and gender were similar in DVT plus PE (63.7 +/- 15.6 years; 49% men) and DVT patients (63.4 +/- 17.3 years; 46% men). Body mass index (BMI) was higher in patients with DVT plus PE (median 29.0, range 15.4-67.0 kg/m(2)) than in patients with DVT (median 26.8, range 9.7-64.4 kg/m(2); p < 0.001). Chronic lung disease (17% vs. 12%; p < 0.001), a personal history of PE (11% vs. 6%; p < 0.001), and a family history of DVT or PE (8% vs. 4%; p < 0.001) were more frequent in DVT plus PE patients. Twenty-seven percent of DVT plus PE patients received prophylaxis prior to the thromboembolic event compared with 32% of DVT patients (p=0.002). Proximal DVT (OR 1.84,95% CI 1.39-2.43), prior PE (OR 1.68,95% CI 1.20-2.35), obesity (BMI > 30 kg/m(2)) (OR 1.65, 95% CI 1.33-2.04), chronic lung disease (OR 1.51, 95% CI 1.13-2.01), as well as omission of prophylaxis (OR 1.30,95% CI 1.04-1.64) emerged as independent predictors of concomitant symptomatic PE.
引用
收藏
页码:494 / 498
页数:5
相关论文
共 28 条
[1]  
ALESSANDRI C, 1994, THROMB HAEMOSTASIS, V72, P343
[2]   The role of thrombosis in severe pulmonary hypertension [J].
Chaouat, A ;
Weitzenblum, E ;
Higenbottam, T .
EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (02) :356-363
[3]   AN IMBALANCE BETWEEN THE EXCRETION OF THROMBOXANE AND PROSTACYCLIN METABOLITES IN PULMONARY-HYPERTENSION [J].
CHRISTMAN, BW ;
MCPHERSON, CD ;
NEWMAN, JH ;
KING, GA ;
BERNARD, GR ;
GROVES, BM ;
LOYD, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (02) :70-75
[4]   Platelet activation in obese women -: Role of inflammation and oxidant stress [J].
Davì, G ;
Guagnano, MT ;
Ciabattoni, G ;
Basili, S ;
Falco, A ;
Marinopiccoli, M ;
Nutini, M ;
Sensi, S ;
Patrono, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (16) :2008-2014
[5]   Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism [J].
Eichinger, S ;
Weltermann, A ;
Minar, E ;
Stain, M ;
Schönauer, V ;
Schneider, B ;
Kyrle, PA .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (01) :92-96
[6]   Prevalence and trends in obesity among US adults, 1999-2000 [J].
Flegal, KM ;
Carroll, MD ;
Ogden, CL ;
Johnson, CL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (14) :1723-1727
[7]   Trends and correlates of class 3 obesity in the United States from 1990 through 2000 [J].
Freedman, DS ;
Khan, LK ;
Serdula, MK ;
Galuska, DA ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (14) :1758-1761
[8]   Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) [J].
Goldhaber, SZ ;
Visani, L ;
De Rosa, M .
LANCET, 1999, 353 (9162) :1386-1389
[9]   A prospective study of risk factors for pulmonary embolism in women [J].
Goldhaber, SZ ;
Grodstein, F ;
Stampfer, MJ ;
Manson, JE ;
Colditz, GA ;
Speizer, FE ;
Willett, WC ;
Hennekens, CH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (08) :642-645
[10]   RISK-FACTORS FOR PULMONARY-EMBOLISM - THE FRAMINGHAM-STUDY [J].
GOLDHABER, SZ ;
SAVAGE, DD ;
GARRISON, RJ ;
CASTELLI, WP ;
KANNEL, WB ;
MCNAMARA, PM ;
GHERARDI, G ;
FEINLEIB, M .
AMERICAN JOURNAL OF MEDICINE, 1983, 74 (06) :1023-1028